Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer

Annals of Thoracic Surgery

Volumn 93, Issue 6, 2012, Pages 1807-1812

  Shah, Asad A ^a   Berry, Mark F ^a   Tzao, Ching ^b   Gandhi, Mihir ^c,d   Worni, Mathias ^a   Pietrobon, Ricardo ^a   D'Amico, Thomas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c Biostatistics   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; MITOMYCIN; PLATINUM DERIVATIVE; VINBLASTINE;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY;

EID: 84861634748     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.03.018     Document Type: Article

References (34)

1. R. Siegel, E. Ward, O. Brawley, A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
3. P. Goldstraw, J.J. Crowley, K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
4. D.S. Ettinger, W. Akerly, G. Bepler Non-small cell lung cancer J Natl Compr Canc Netw 8 2010 740 801
5. R. Rosell, J. Gomez-Codina, C. Camps A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153 158
6. J.A. Roth, E.N. Atkinson, F. Fossella Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
7. B.Z. Atkins, T.A. D'Amico Controversial issues regarding the use of induction chemotherapy for lung cancer Semin Thorac Cardiovasc Surg 17 2005 191 194
8. Song WA, Zhou NK, Wang W, et al. Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials. J Thorac Oncol 5:510-6.
9. Phase III randomized trial of preoperative chemotherapy versus preoperative concurrent chemotherapy and thoracic radiotherapy followed by surgical resection and consolidation chemotherapy in favorable prognosis patients with stage IIIA (N2) non-small cell lung cancer: RTOG 0412/SWOG S0332 http://www.rtog.org/members/protocols/0412/0412.pdf Accessed July 11, 2011
10. A. Liberati, D.G. Altman, J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100
11. N. Girard, F. Mornex, J.Y. Douillard Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial Lung Cancer 69 2010 86 93
12. J. Fleck, J. Carmargo, D. Godoy Chemoradiation therapy (CRT) versus chemotherapy (CT) alone as a neoadjuvant treatment for stage III non-small cell lung cancer (NSCLC) Preliminary report of a phase III prospective randomized trial Proc Am Soc Clin Oncol 12 1993 333
13. J. Sauvaget, J. Rebischung, J. Vannetzel Phase III study of neo-adjuvant MVP versus MVP plus chemo-radiation in stage III NSCLC Proc Am Soc Clin Oncol 19 2000 495a
14. M. Thomas, C. Rübe, P. Hoffknecht Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small cell lung cancer Lancet Oncol 9 2008 636 648
15. E. Pezzetta, R. Stupp, A. Zouhair Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC Eur J Cardiothorac Surg 27 2005 1092 1098
16. J. Li, C.H. Dai, S.B. Shi, P. Chen, L.C. Yu, J.R. Wu Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients Ann Thorac Med 4 2009 201 207
17. M.K. Parmar, V. Torri, L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
18. M. Borenstein, L. Hedges, J. Higgins An introduction to meta-analysis 2009 John Wiley and Sons West Sussex, UK
19. Review Manager (RevMan) [Computer program]. Version 5.0 2008 The Nordic Cochrane Centre, The Cochrane Collaboration Copenhagen
20. M. Semik, D. Riesenbeck, A. Linder Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer Eur J Cardiothorac Surg 26 2004 1205 1210
21. K. Higgins, J.P. Chino, L.B. Marks Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer Int J Radiat Oncol Biol Phys 75 2009 1462 1467
22. K.S. Albain, R.S. Swann, V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
23. L.A. Robinson, J.C. Ruckdeschel, H. Wagner Jr Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd ed) Chest 132 3 Suppl 2007 243S 265S
24. D.C. Betticher, S.F. Hsu Schmitz, M. Totsch Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759
25. L. Voltolini, L. Luzzi, C. Ghiribelli, P. Paladini, M. Di Bisceglie, G. Gotti Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy Eur J Cardiothorac Surg 20 2001 1106 1112
26. K.S. Albain, V.W. Rusch, J.J. Crowley Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery in stage IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
27. C. Doddoli, F. Barlesi, D. Trousse One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits J Thorac Cardiovasc Surg 130 2005 416 425
28. J.R. Sonett, M. Suntharalingam, M.J. Edelman Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer Ann Thorac Surg 78 2004 1200 1205
29. P. Bonomi, L.P. Faber, W. Warren Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation Semin Oncol 24 4 Suppl 12 1997 23 129
30. W.C. Fowler, C.J. Langer, W.J. Curran Postoperative complications after combined neoadjuvant treatment of lung cancer Ann Thorac Surg 55 1993 986 989
31. S. Fujita, N. Katakami, Y. Takahashi Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer Eur J Cardiothorac Surg 29 2006 896 901
32. F.M. Kong, R. Ten Haken, A. Eisbruch, T.S. Lawrence Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis Semin Oncol 32 2 Suppl 3 2005 S42 S54
33. L.B. Marks, X. Yu, R.G. Prosnitz The incidence and functional consequences of RT-associated cardiac perfusion defects Int J Radiat Oncol Biol Phys 63 2005 214 223
34. D.J. Sher Cost-effectiveness studies in radiation therapy Expert Rev Pharmacoecon Outcomes Res 10 2010 567 582